Failure of endogenous blood kinin levels elevated by captopril to induce hypotension in normotensive and hypertensive rats: A study using a newly developed ELISA for kinin

Biomedical Research

Volumn 17, Issue 1, 1996, Pages 15-25

  Majima, Masataka ^a   Katori, Makoto ^a   Ogino, Michiko ^a   Saito, Maki ^a   Sugimoto, Katsuhiko ^a   Adachi, Keiichi ^a   Ohno, Takashi ^a   Sunahara, Noriyuki ^b   Katoh, Koichi ^b   Tatemichi, Noriyuki ^c   Takei, Yoshifumi ^c  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c Maruko Pharmaceutical Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTIHYPERTENSIVE AGENT; BRADYKININ; CAPTOPRIL; DEOXYCORTICOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KININ; PHOSPHOTRANSFERASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART RATE; HYPOTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 13344277351     PISSN: 03886107     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.17.15     Document Type: Article

References (40)

1. ABE K., WATANABE N. and KUMAGAI K. (1966) Estimation of kinin in peripheral blood in man. Tohoku J. Exp. Med. 89, 103-112
2. ADACHI K., MAJIMA M., KATORI M. and NISHIJIMA M. (1995) Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats. Jap. J. Pharmacol. 67, 243-252
3. AUBERT J. E., WAEBER B., NUSSBERGER J., VAVREK R., STEWART J. M. and BRUNER H. R. (1987) Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin convening enzyme inhibition in rats. Agents Actions 22, 349-354
4. BAO G., GOHLKE P., QUADRI F. and UNGER T. (1992) Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension 20, 74-79
5. BAO G., GOHLKE P. and UNGER T. (1992) Role of bradykinin in chronic anti-hypertensive actions of ramipril in different hypertension models. J. Cardiovasc. Pharmacol. 20, S96-S99
6. BAO G., QUADRI F., STAUSS B., STAUSS H., GOHLKE P. and UNGER T. (1991) Hoe140, a new highly potent and long-acting bradykinin antagonist in conscious rats. Eur. J. Pharmacol. 200, 179-182
7. BENETOS A., GRAVAS I. and GRAVAS H. (1986) Hypertensive effect of a bradykinin antagonist in normotensive rats. Hypertension 8, 1089-1092
8. BONNER G., PREIS S., SCHUNK U., TOUSSAINT C. and KAUFMANN W. (1990) Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J. Cardiovasc. Pharmacol. 15, S46-S56
9. BROCKLEHURST W. E. and ZEITOLIN L. J. (1967) Determination of plasma kinin and kininogen levels in man. J. Physiol. 191, 417-426
10. CHRISTINA, M., RABITO S. F. and CARRETERO O. A. (1986) Blood kinin in one-kidney, one clip hypertensive rats. Hypertension 8, Suppl. 1, I-110-113
11. FERREIRA S. H. and VANE J. R. (1967) The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Brit. J. Pharmacol. 30, 417-424
12. GAUTVIK K. M., HILTON S. M. and TORRES S. H. (1970) Consumption of kininogen in the submandibular salivary gland when activated by chorda stimulation. J. Physiol. 201. 49-61
13. GRIESBACHER T. and LEMBECK F. (1992) Effect of the bradykinin antagonist. Hoe140, in experimental acute pancreatitis. Brit. J. Pharmacol. 107, 356-360
14. HASHIMOTO K., HAMAMOTO H., HONDA Y. HIROSE M., FURUKAWA S. and KIMURA E. (1978) Changes in components of kinin system and hemodynamics in acute myocardial infarction. Amer. Heart J. 95, 619-626
15. KAMIYA T., KATAYAMA Y., KASHIWAGI F. and TERASHI A. (1993) The role of bradykinin in mediating ischemic brain edema in rats. Stroke 24, 571-576
16. KATORI M., MAJIMA M., ODOI-ADOME R., SUNAHARA N. and UCHIDA Y. (1989) Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats. Brit. J. Pharmacol. 78, 1383-1391
17. LAWTON W. J., PROUD D., FRENCH M. E., PIERCE J. V., KEISER H. R., PISANO J. J., LAZARUS G. S., YOST F. J. and THOMAS C. A. (1981) Characterization and origin of immunoreactive glandular kallikrein in rat plasma. Biochem. Pharmacol. 30, 1731-1737
18. LOWRY O. H., ROSENBROUGH N. J., FARR A. L. and RANDALL R. J. (1951) Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-275
19. MAJIMA M., ADACHI K., KURIBAYASHI Y. and KATORI M. (1995) Sodium accumulation by high sodium infusion increases sensitivity to vasoconstrictors in kinogen-deficient Brown Norway Katholiek rats. Jap. J. Pharmacol. 67, Suppl. 1, 266
20. MAJIMA M., KATORI M., HANAZUKA M., MIZOGAMI S., NAKANO T., NAKAO Y., MIKAMI R., URYU H., OKAMURA R., MOHSIN S. S. J. and OH-ISHI S. (1991) Suppression of rat deoxycorticosterone-salt hypertension by the kallikreinkinin system. Hypertension 17, 806-813
21. MAJIMA M., KURIBAYASHI Y., IKEDA Y., ADACHI K., KATORI M. and KATO H. (1994) Diuretic and natriuretic effect of a selective inhibitor of a urinary carboxypeptidase Y-like kininase, ebelactone B, in anesthetized rats. Jap. J. Pharmacol. 65, 79-82
22. MAJIMA M., MIZOGAMI S., KURIBAYASHI Y., KATORI M. and OH-ISHI S. (1994) Hypertension induced by a non-pressor dose of angiotensin II in kininogen-deficient rats. Hypertension 24, 111-120
23. MAJIMA M., SHIMA C., SAITO M., KURIBAYASHI Y., KATORI M. and AOYAGI T. (1993) Poststatin, a novel inhibitor of bradykinin-degrading enzymes in rat urine. Eur. J. Pharmacol. 232, 181-190
24. MAJIMA M., SUNAHARA N., HARADA Y. and KATORI M. (1993) Detection of the degradation products of bradykinin by enzyme immunoassays as useful markers of the release of kinin in vivo. Biochem. Pharmacol. 45, 559-567
25. MAJIMA M., UENO A., SUNAHARA N. and KATORI M. (1989) Measurement of des-Phe8-Arg9-bradykinin by enzyme immunoassay: A useful parameter of plasma kinin release. In Adv. Exp. Med. Biol. 247B, Kinin V, Part B (ed. ABE K., MORIYA H. and FUJII S.), Plenum. New York, pp. 535-540
26. MAJIMA M., YOSHIDA O., MIHARA H., MUTO T., MIZOGAMI S., KURIBAYASHI Y, KATORI M. and OH-ISHI S. (1993) High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. Hypertension 22, 705-714
27. MOHSIN S. S. J., MAJIMA M., KATORI M. and SHARMA J. N. (1992) Important suppressive roles of the kallikrein-kinin system during the developmental stage of hypertension in spontaneously hypertensive rats. Asia Pacific J. Pharmacol. 7, 73-82
28. NAKAGAWA M. and NASJLETTI A. (1988) Plasma kinin concentration in deoxycorticosterone-salt hypertension. Hypertension 11, 411-415
29. NOLLY H., SCICLI A. G., SCICLI G. and CARRETERO O. A. (1985) Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein. Circ. Res. 56, 816-821
30. NUSTAD K., ORSTAVIK T. B. and GAUTIVIK K. M. (1987) Radioimmunological measurements of rat submandibular gland kallikrein (RSK) in tissues and serum. Microvasc. Res. 15, 115a
31. OZA N. B. and GOUD H. D. (1992) Kininogenase of the aortic wall in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 20, S1-S3
32. SCICLI A. G., MINDROIU T., SCICLI G. and CARRETERO O. A. (1982) Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen. J. Lab. Clin. Med. 100, 81-93
33. SEAD G. M., CARRETERO O. A., MACDONALD R. J. and SCICLI A. G. (1990) Kallikrein messenger RNA in rat arteries and veins. Circ. Res. 67, 510-516
34. SHIMA C., MAJIMA M. and KATORI M. (1992) A stable metabolite of bradykinin, Arg-Pro-Pro-Gly-Phe, in the degradation in human plasma. Jap. J. Pharmacol. 60, 111-119
35. SHIMAMOTO K., ANDO T., TANAKA S. and IIMURA O. (1988) The determination of kinin and glandular kallikrein in human biolgoical fluids. Atemw-Lungenkrkh Jahrgang 14, S29-S36
36. UCHIDA Y., TANAKA K., HARADA Y., UENO A. and KATORI M. (1983) Activation of plasma kallikrein-kinin system and its significant role in rat carrageenan-induced pleurisy. Inflammation 7, 121-131
37. VANE J. R. (1969) The release and fate of vasoactive hormones in the circulation. Brit. J. Pharmacol. 35, 209-242
38. VIO C. P. and FIGUEROA C. D. (1985) Subcellular localization of renal kallikrein by ultrastructural immunocytochemistry. Kidney Int. 28, 36-42
39. WAEBER B., AUBERT J. F., VAVREK R., STEWART J. M., NUSSBERGER J. and BRUNER H. R. (1986) Role of bradykinin in blood pressure regulation of conscious spontaneously hypertensive rats. J. Hypertens. 4, Suppl. 6, S597-S598
40. WIRTH K., HOCK F. J., ALBUS U., LINZ W., ALPERMANN H. G., ANAGNOSTOPOULOS H., HENKE S., BREIPOHL G., KONIG W. and SCHOLKENS B. A. (1991) Hoe140, a new potent and long acting bradykinin-antagonist: in vivo studies. Brit. J. Pharmacol. 102, 774-777